UDP-glucuronosyltransferase 1-3
Details
- Name
- UDP-glucuronosyltransferase 1-3
- Synonyms
- 2.4.1.17
- GNT1
- UDP-glucuronosyltransferase 1-C
- UDP-glucuronosyltransferase 1A3
- UDPGT 1-3
- UGT-1C
- UGT1
- UGT1C
- Gene Name
- UGT1A3
- Organism
- Humans
- Amino acid sequence
>lcl|BSEQ0007065|UDP-glucuronosyltransferase 1-3 MATGLQVPLPWLATGLLLLLSVQPWAESGKVLVVPIDGSHWLSMREVLRELHARGHQAVV LTPEVNMHIKEENFFTLTTYAISWTQDEFDRHVLGHTQLYFETEHFLKKFFRSMAMLNNM SLVYHRSCVELLHNEALIRHLNATSFDVVLTDPVNLCAAVLAKYLSIPTVFFLRNIPCDL DFKGTQCPNPSSYIPRLLTTNSDHMTFMQRVKNMLYPLALSYICHAFSAPYASLASELFQ REVSVVDILSHASVWLFRGDFVMDYPRPIMPNMVFIGGINCANRKPLSQEFEAYINASGE HGIVVFSLGSMVSEIPEKKAMAIADALGKIPQTVLWRYTGTRPSNLANNTILVKWLPQND LLGHPMTRAFITHAGSHGVYESICNGVPMVMMPLFGDQMDNAKRMETKGAGVTLNVLEMT SEDLENALKAVINDKSYKENIMRLSSLHKDRPVEPLDLAVFWVEFVMRHKGAPHLRPAAH DLTWYQYHSLDVIGFLLAVVLTVAFITFKCCAYGYRKCLGKKGRVKKAHKSKTH
- Number of residues
- 534
- Molecular Weight
- 60337.835
- Theoretical pI
- 8.28
- GO Classification
- Functionsenzyme binding / glucuronosyltransferase activity / protein heterodimerization activity / protein homodimerization activity / retinoic acid bindingProcessescellular glucuronidation / cellular response to hormone stimulus / flavonoid biosynthetic process / flavonoid glucuronidation / metabolic process / negative regulation of cellular glucuronidation / negative regulation of fatty acid metabolic process / negative regulation of glucuronosyltransferase activity / retinoic acid metabolic process / xenobiotic glucuronidationComponentsendoplasmic reticulum / endoplasmic reticulum membrane / integral component of membrane
- General Function
- Retinoic acid binding
- Specific Function
- UDPGT is of major importance in the conjugation and subsequent elimination of potentially toxic xenobiotics and endogenous compounds. Isoform 2 lacks transferase activity but acts as a negative regulator of isoform 1.
- Pfam Domain Function
- UDPGT (PF00201)
- Transmembrane Regions
- 492-508
- Cellular Location
- Microsome
- Gene sequence
>lcl|BSEQ0017182|UDP-glucuronosyltransferase 1-3 (UGT1A3) ATGGCCACAGGACTCCAGGTTCCCCTGCCGTGGCTGGCCACAGGACTGCTGCTTCTCCTC AGTGTCCAGCCCTGGGCTGAGAGTGGAAAGGTGTTGGTGGTGCCCATTGATGGCAGCCAC TGGCTCAGCATGCGGGAGGTCTTGCGGGAGCTCCATGCCAGAGGCCACCAGGCAGTGGTC CTCACCCCAGAGGTGAATATGCACATCAAAGAAGAGAACTTTTTCACCCTGACAACCTAT GCCATTTCGTGGACCCAGGATGAATTTGATCGCCATGTGCTGGGCCACACTCAACTGTAC TTTGAAACAGAACATTTTCTGAAGAAATTTTTCAGAAGTATGGCAATGTTGAACAATATG TCTTTGGTCTATCATAGGTCTTGTGTGGAGCTACTACATAATGAGGCCCTGATCAGGCAC CTGAATGCTACTTCCTTTGATGTGGTTTTAACAGACCCCGTTAACCTCTGCGCGGCAGTG CTGGCTAAGTACCTGTCGATTCCTACTGTGTTTTTTTTGAGGAACATTCCATGTGATTTA GACTTTAAGGGCACACAGTGTCCAAACCCTTCCTCCTATATTCCTAGATTACTAACAACC AATTCAGACCACATGACATTCATGCAAAGGGTCAAGAACATGCTCTACCCTCTGGCCCTG TCCTACATTTGCCATGCTTTTTCTGCTCCTTATGCAAGCCTTGCCTCTGAGCTTTTTCAG AGAGAGGTGTCAGTGGTGGATATTCTCAGTCATGCATCTGTGTGGCTGTTCCGAGGGGAC TTTGTGATGGACTACCCCAGGCCAATCATGCCCAACATGGTCTTCATTGGGGGCATCAAC TGTGCCAACAGGAAGCCACTATCTCAGGAATTTGAAGCCTACATTAATGCTTCTGGAGAA CATGGAATTGTGGTTTTCTCTTTGGGATCAATGGTCTCAGAAATTCCAGAGAAGAAAGCT ATGGCAATTGCTGATGCTTTGGGCAAAATCCCTCAGACAGTCCTGTGGCGGTACACTGGA ACCCGACCATCGAATCTTGCGAACAACACGATACTTGTTAAGTGGCTACCCCAAAACGAT CTGCTTGGTCACCCGATGACCCGTGCCTTTATCACCCATGCTGGTTCCCATGGTGTTTAT GAAAGCATATGCAATGGCGTTCCCATGGTGATGATGCCCTTGTTTGGTGATCAGATGGAC AATGCAAAGCGCATGGAGACTAAGGGAGCTGGAGTGACCCTGAATGTTCTGGAAATGACT TCTGAAGATTTAGAAAATGCTCTAAAAGCAGTCATCAATGACAAAAGTTACAAGGAGAAC ATCATGCGCCTCTCCAGCCTTCACAAGGACCGCCCGGTGGAGCCGCTGGACCTGGCCGTG TTCTGGGTGGAGTTTGTGATGAGGCACAAGGGCGCGCCACACCTGCGCCCCGCAGCCCAC GACCTCACCTGGTACCAGTACCATTCCTTGGACGTGATTGGTTTCCTCTTGGCCGTCGTG CTGACAGTGGCCTTCATCACCTTTAAATGTTGTGCTTATGGCTACCGGAAATGCTTGGGG AAAAAAGGGCGAGTTAAGAAAGCCCACAAATCCAAGACCCATTGA
- Chromosome Location
- 2
- Locus
- 2q37
- External Identifiers
Resource Link UniProtKB ID P35503 UniProtKB Entry Name UD13_HUMAN GenBank Protein ID 340135 GenBank Gene ID M84127 HGNC ID HGNC:12535 - General References
- Ritter JK, Chen F, Sheen YY, Tran HM, Kimura S, Yeatman MT, Owens IS: A novel complex locus UGT1 encodes human bilirubin, phenol, and other UDP-glucuronosyltransferase isozymes with identical carboxyl termini. J Biol Chem. 1992 Feb 15;267(5):3257-61. [Article]
- Gong QH, Cho JW, Huang T, Potter C, Gholami N, Basu NK, Kubota S, Carvalho S, Pennington MW, Owens IS, Popescu NC: Thirteen UDPglucuronosyltransferase genes are encoded at the human UGT1 gene complex locus. Pharmacogenetics. 2001 Jun;11(4):357-68. [Article]
- Hillier LW, Graves TA, Fulton RS, Fulton LA, Pepin KH, Minx P, Wagner-McPherson C, Layman D, Wylie K, Sekhon M, Becker MC, Fewell GA, Delehaunty KD, Miner TL, Nash WE, Kremitzki C, Oddy L, Du H, Sun H, Bradshaw-Cordum H, Ali J, Carter J, Cordes M, Harris A, Isak A, van Brunt A, Nguyen C, Du F, Courtney L, Kalicki J, Ozersky P, Abbott S, Armstrong J, Belter EA, Caruso L, Cedroni M, Cotton M, Davidson T, Desai A, Elliott G, Erb T, Fronick C, Gaige T, Haakenson W, Haglund K, Holmes A, Harkins R, Kim K, Kruchowski SS, Strong CM, Grewal N, Goyea E, Hou S, Levy A, Martinka S, Mead K, McLellan MD, Meyer R, Randall-Maher J, Tomlinson C, Dauphin-Kohlberg S, Kozlowicz-Reilly A, Shah N, Swearengen-Shahid S, Snider J, Strong JT, Thompson J, Yoakum M, Leonard S, Pearman C, Trani L, Radionenko M, Waligorski JE, Wang C, Rock SM, Tin-Wollam AM, Maupin R, Latreille P, Wendl MC, Yang SP, Pohl C, Wallis JW, Spieth J, Bieri TA, Berkowicz N, Nelson JO, Osborne J, Ding L, Meyer R, Sabo A, Shotland Y, Sinha P, Wohldmann PE, Cook LL, Hickenbotham MT, Eldred J, Williams D, Jones TA, She X, Ciccarelli FD, Izaurralde E, Taylor J, Schmutz J, Myers RM, Cox DR, Huang X, McPherson JD, Mardis ER, Clifton SW, Warren WC, Chinwalla AT, Eddy SR, Marra MA, Ovcharenko I, Furey TS, Miller W, Eichler EE, Bork P, Suyama M, Torrents D, Waterston RH, Wilson RK: Generation and annotation of the DNA sequences of human chromosomes 2 and 4. Nature. 2005 Apr 7;434(7034):724-31. [Article]
- Alonen A, Finel M, Kostiainen R: The human UDP-glucuronosyltransferase UGT1A3 is highly selective towards N2 in the tetrazole ring of losartan, candesartan, and zolarsartan. Biochem Pharmacol. 2008 Sep 15;76(6):763-72. doi: 10.1016/j.bcp.2008.07.006. Epub 2008 Jul 12. [Article]
- Bellemare J, Rouleau M, Girard H, Harvey M, Guillemette C: Alternatively spliced products of the UGT1A gene interact with the enzymatically active proteins to inhibit glucuronosyltransferase activity in vitro. Drug Metab Dispos. 2010 Oct;38(10):1785-9. doi: 10.1124/dmd.110.034835. Epub 2010 Jul 7. [Article]
- Girard H, Levesque E, Bellemare J, Journault K, Caillier B, Guillemette C: Genetic diversity at the UGT1 locus is amplified by a novel 3' alternative splicing mechanism leading to nine additional UGT1A proteins that act as regulators of glucuronidation activity. Pharmacogenet Genomics. 2007 Dec;17(12):1077-89. [Article]
- Chen R, Jiang X, Sun D, Han G, Wang F, Ye M, Wang L, Zou H: Glycoproteomics analysis of human liver tissue by combination of multiple enzyme digestion and hydrazide chemistry. J Proteome Res. 2009 Feb;8(2):651-61. doi: 10.1021/pr8008012. [Article]
- Menard V, Girard H, Harvey M, Perusse L, Guillemette C: Analysis of inherited genetic variations at the UGT1 locus in the French-Canadian population. Hum Mutat. 2009 Apr;30(4):677-87. doi: 10.1002/humu.20946. [Article]
Drug Relations
- Drug Relations
DrugBank ID Name Drug group Pharmacological action? Actions Details DB00796 Candesartan cilexetil approved unknown substrate Details DB01029 Irbesartan approved, investigational unknown substrate Details DB00678 Losartan approved unknown substrate Details DB00749 Etodolac approved, investigational, vet_approved unknown substrate Details DB00712 Flurbiprofen approved, investigational unknown substrate Details DB01050 Ibuprofen approved unknown substrate Details DB00327 Hydromorphone approved, illicit no substrate Details DB01252 Mitiglinide investigational unknown substrate Details DB04725 Licofelone investigational unknown substrate Details DB06741 Gavestinel investigational unknown substrate Details DB06210 Eltrombopag approved unknown substrate Details DB06403 Ambrisentan approved, investigational unknown substrate Details DB00197 Troglitazone approved, investigational, withdrawn unknown substrate Details DB00295 Morphine approved, investigational no substrate Details DB00973 Ezetimibe approved unknown substrate Details DB06510 Muraglitazar investigational unknown substrate Details DB00434 Cyproheptadine approved unknown substrate Details DB04953 Ezogabine approved, investigational unknown substrate Details DB08860 Pitavastatin approved unknown substrate Details DB01076 Atorvastatin approved no substrate Details DB00227 Lovastatin approved, investigational unknown substrate Details DB00641 Simvastatin approved unknown substrate Details DB01544 Flunitrazepam approved, illicit unknown inhibitor Details DB01095 Fluvastatin approved unknown substrate Details DB00313 Valproic acid approved, investigational unknown substrate Details DB11943 Delafloxacin approved, investigational no substrate Details DB11691 Naldemedine approved, investigational no substrate Details DB13874 Enasidenib approved, investigational unknown substrate Details DB13919 Candesartan experimental unknown substrate Details DB12070 Letermovir approved, investigational no substrate Details DB06230 Nalmefene approved, investigational, withdrawn no substrate Details DB08930 Dolutegravir approved no substrate Details DB05928 Dovitinib investigational unknown inhibitor Details DB01609 Deferasirox approved, investigational unknown inhibitor Details DB09213 Dexibuprofen approved, investigational unknown substrate Details DB13997 Baloxavir marboxil approved, investigational no substrate Details DB00966 Telmisartan approved, investigational unknown substrate Details DB01241 Gemfibrozil approved unknown substrateinhibitor Details DB12130 Lorlatinib approved, investigational unknown substrate Details DB00788 Naproxen approved, vet_approved unknown substrate Details DB00586 Diclofenac approved, vet_approved unknown substrate Details DB00455 Loratadine approved, investigational unknown Details DB01217 Anastrozole approved, investigational unknown substrate Details DB00977 Ethinylestradiol approved unknown Details DB11689 Selumetinib approved, investigational no Details DB09038 Empagliflozin approved unknown substrate Details DB00920 Ketotifen approved unknown substrate Details DB04854 Febuxostat approved no substrate Details DB08893 Mirabegron approved no substrate Details DB08804 Nandrolone decanoate approved, illicit unknown substrate Details DB12020 Tecovirimat approved, investigational unknown substrate Details DB00470 Dronabinol approved, illicit no substrate Details DB06700 Desvenlafaxine approved, investigational no substrate Details DB15114 Vamorolone approved, investigational no substrate Details DB16200 Iptacopan approved, investigational no substrate Details DB00555 Lamotrigine approved, investigational unknown substrate Details DB00503 Ritonavir approved, investigational no inducer Details DB14635 Curcumin sulfate experimental unknown inhibitor Details DB00794 Primidone approved, vet_approved unknown inducer Details DB00783 Estradiol approved, investigational, vet_approved unknown substrateinducer Details DB00714 Apomorphine approved, investigational unknown substrate Details DB11796 Fostemsavir approved, investigational unknown substrate Details DB00871 Terbutaline approved unknown substrate Details DB00960 Pindolol approved, investigational unknown substrate Details DB12471 Ibrexafungerp approved, investigational unknown substrate Details